clenbuterol and leuprolide

clenbuterol has been researched along with leuprolide in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M	1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ	1
Fischbeck, KH; Fratta, P; Hashizume, A; Katsuno, M; Pennuto, M	1

Reviews

1 review(s) available for clenbuterol and leuprolide

Article	Year
Disease mechanism, biomarker and therapeutics for spinal and bulbar muscular atrophy (SBMA). Journal of neurology, neurosurgery, and psychiatry, 2020, Volume: 91, Issue:10 Topics: 5-alpha Reductase Inhibitors; Adipose Tissue; Adrenergic beta-Agonists; Autophagy; Biomarkers; Bulbo-Spinal Atrophy, X-Linked; Clenbuterol; Creatinine; Dutasteride; Glycolysis; Humans; Insulin-Like Growth Factor I; Leuprolide; Magnetic Resonance Imaging; Mitochondria; Muscle Fibers, Fast-Twitch; Muscle Fibers, Slow-Twitch; Muscle, Skeletal; Oligonucleotides, Antisense; Oxidation-Reduction; Receptors, Androgen; RNAi Therapeutics; Trinucleotide Repeat Expansion	2020

Article

Year

Disease mechanism, biomarker and therapeutics for spinal and bulbar muscular atrophy (SBMA).

Journal of neurology, neurosurgery, and psychiatry, 2020, Volume: 91, Issue:10

Topics: 5-alpha Reductase Inhibitors; Adipose Tissue; Adrenergic beta-Agonists; Autophagy; Biomarkers; Bulbo-Spinal Atrophy, X-Linked; Clenbuterol; Creatinine; Dutasteride; Glycolysis; Humans; Insulin-Like Growth Factor I; Leuprolide; Magnetic Resonance Imaging; Mitochondria; Muscle Fibers, Fast-Twitch; Muscle Fibers, Slow-Twitch; Muscle, Skeletal; Oligonucleotides, Antisense; Oxidation-Reduction; Receptors, Androgen; RNAi Therapeutics; Trinucleotide Repeat Expansion

2020

Other Studies

2 other study(ies) available for clenbuterol and leuprolide

Article	Year
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21 Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship	2008
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6 Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics	2010